- Home
- EWBC vs PODD Comparison
EWBC vs PODD Comparison
Compare EWBC & PODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EWBC | PODD |
|---|---|---|
| Founded | 1998 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.3B | 17.0B |
| IPO Year | 1998 | 2007 |
Fundamental Metrics
Financial Performance| Metric | EWBC | PODD |
|---|---|---|
| Price | $115.54 | $196.88 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 20 |
| Target Price | $126.54 | ★ $349.80 |
| AVG Volume (30 Days) | ★ 976.7K | 874.8K |
| Earning Date | 04-21-2026 | 05-06-2026 |
| Dividend Yield | ★ 2.74% | N/A |
| EPS Growth | ★ 14.29 | N/A |
| EPS | ★ 9.52 | 3.48 |
| Revenue | $55,316,000.00 | ★ $2,708,100,000.00 |
| Revenue This Year | $13.01 | $24.59 |
| Revenue Next Year | $5.38 | $19.18 |
| P/E Ratio | ★ $12.26 | $57.22 |
| Revenue Growth | 3.12 | ★ 30.73 |
| 52 Week Low | $72.18 | $197.54 |
| 52 Week High | $123.82 | $354.88 |
Technical Indicators
Market Signals| Indicator | EWBC | PODD |
|---|---|---|
| Relative Strength Index (RSI) | 64.25 | 22.91 |
| Support Level | $114.38 | N/A |
| Resistance Level | $118.19 | $299.75 |
| Average True Range (ATR) | 2.34 | 6.96 |
| MACD | 1.54 | -0.67 |
| Stochastic Oscillator | 87.50 | 4.49 |
Price Performance
Historical ComparisonAbout EWBC East West Bancorp Inc.
East West Bancorp Inc operates in U.S. and Asia. The Bank provides range of personal and commercial banking services to individuals and businesses. In addition to offering traditional deposit products that include personal and business checking and savings accounts, money market, and time deposits, the Bank also offers foreign exchange, treasury management and wealth management services. The Bank has three operating segments, (1) Consumer and Business Banking, (2) Commercial Banking and (3) Treasury and Other. The company generates the majority of its revenue from the Commercial banking segment.
About PODD Insulet Corporation
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.